New Perspectives in Advanced Genitourinary Malignancies-Reference-Cited by-同舟云学术

New Perspectives in Advanced Genitourinary Malignancies

Published:2012-03 Issue:2 Volume:98 Page:267-269
ISSN:0300-8916
Container-title:Tumori Journal
language:en
Short-container-title:Tumori

Author:

Biondani Pamela¹,Procopio Giuseppe¹,Pietrantonio Filippo¹,De Braud Filippo¹,Verzoni Elena¹

Affiliation:

1. Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Abstract

The management of advanced genitourinary malignancies has undergone a major transformation with the advent of novel drugs and targeted therapies in recent years. Assessment of the treatment risks and benefits is required for each patient and therefore better knowledge of the different clinical and molecular aspects of these diseases is warranted. The results of further studies and biomarker validations are expected to provide more treatment options and improve outcomes in the future management of genitourinary malignancies.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/030089161209800215

Reference22 articles.

1. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

2. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

3. Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

4. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

5. Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Episensitization;Drug Discovery in Cancer Epigenetics;2016